Idera Pharmaceuticals,Inc. (NASDAQ:IDRA) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07. Submission of Matters to a Vote of Security Holders.
At the special meeting of stockholders of Idera Pharmaceuticals,Inc. (the “Company”) held on January4, 2018, the Company’s stockholders voted in the following manner with respect to the following proposals:
1. The stockholders approved an amendment to the Company’s Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the Company’s issued and outstanding common stock by a whole number ratio of not less than 1-for-4 and not more than 1-for-8, such ratio and the implementation and timing of such reverse stock split to be determined in the discretion of the Company’s board of directors at any time prior to the Company’s 2018 annual meeting of stockholders, and, in connection therewith, to decrease the number of authorized shares of the Company’s common stock on a basis proportional to the reverse stock split ratio.
|
For: |
134,445,427 |
|
Against: |
17,488,433 |
|
Abstain: |
404,020 |
|
Broker Non-Votes: |
|
2. The stockholders approved an amendment to the Company’s Restated Certificate of Incorporation, as amended, to set the number of authorized shares of the Company’s common stock at a number determined by calculating the product of 280,000,000 multiplied by two times (2x) the reverse stock split ratio.
|
For: |
127,671,942 |
|
Against: |
24,130,768 |
|
Abstain: |
535,170 |
|
Broker Non-Votes: |
|